“…These include subcutaneous xenograft model (Mareinfeld et al, 2003;Fava et al, 2005;Jimeno et al, 2005) or hepatobiliary CCA model (Johnson et al, 2001;Voskoglou-Nomokos et al, 2003;Bibby, 2004;Sausville and Burger, 2006) in hamsters or rats after treatment with carcinogens [N-nitrosobis (2-oxopropyl) amine, methylazoxymethyl acetate, dimethylnitrosamine, furan, thioacetamide] or infection with O. viverrini (OV) (Maronpot et al, 1991;Imray et al, 1992;Thamavit et al, 1993;Iki et al, 1998;Jan et al, 2007;Tesana et al, 2007), and genetic CCA models (Lai et al, 2005;Xu et al, 2006;Sirica et al, 2008). In our study, OV/DMN induced CCA in hamster model was used.…”